Moderator and Associate Editor Timothy Spicer leads the December 2020 SLAS Discovery Special Issue on Drug Discovery Targeting COVID-19. Select authors will share their research, followed by open discussion and Q&A.
Authors will present the following publications:
- A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19
- CETSA® MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies Trip13 as a Remdesivir Off-target
- Repurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19
- RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery
$20 for Non-Member